In Germany, they thought about delaying the second vaccination, and in Denmark, the interval between the two doses had already been extended.

Coronavirus – the second year

It has been more than a year since the Chinese authorities informed the WHO of the emergence of a new, rapidly spreading virus. Since then, there has hardly been a person in the world who has not heard the term Covid19, and more and more people are mourning the family member or friend with whom the new disease ended as stocks collapsed within weeks and our entire lives were rewritten. by the epidemic. By now, the vaccines have been completed, which in turn raises not only hope, but again many questions, while not only stopping the virus, but also threatening another mutation. You will find the details of this fight in our series of articles.

German biotech company BioNTech and its American partner Pfizer warned in Frankfurt on Monday that there was no evidence that the vaccine they jointly developed against the coronavirus would be effective if the second dose was administered later than at the time of the trials.

“The safety and efficacy of the vaccine have not been studied at different dosing timeframes; the majority of trial participants received the second dose of the vaccine at the intervals specified in the study,” the two companies said in a statement. set. past. The prospectus emphasizes:

“We have no evidence that protection is maintained beyond 21 days after the first dose.”

Germany on Monday considered delaying the administration of the second vaccine dose by studying the British example, while Denmark decided to extend the interval between the administration of the two vaccines to six weeks.

[Itt a naptár: mire számíthat, aki beadatja magának a Pfizer 95%-os koronavírus-vakcináját?]

If you want to know about similar things at other times, you will like the HVG Tech Facebook page, which also offers scientific news.



The number of independent publishing offices of power is steadily declining, and those that still exist are trying to stay afloat with a growing headwind. At HVG we persevere, we do not give in to pressure and we bring national and international news every day.

That is why we ask you, our readers, to support us, support us, join our membership and renew it!

And we promise to keep doing our best for you in all circumstances!

The European Commission is in talks with Pfizer / BioNTech to buy more vaccines



MTI
Economy

The 300 million servings previously ordered would be supplemented by the EC.

Up to six doses of vaccine can be drawn from the Pfizer / BioNTech vials instead of the previous five



hvg.hu
Technology

According to BioNTech, if the injection needle and syringe are suitable, up to six doses of the vaccine can be drawn from a vial instead of the previous five.